Ann Elizabeth Woolfrey MD

Pediatric Hematology & Oncology•Seattle, WA

Professor of Medicine, University Wash

Join to View Full Profile

825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-288-1000

Education & Training

Yale UniversityPost-Doctoral Fellowship, 1994 - 1996
University of WashingtonFellowship, Pediatric Hematology/Oncology, 1989 - 1992
University of ChicagoResidency, Internal Medicine/Pediatrics, 1984 - 1988
University of Minnesota Medical SchoolClass of 1984

Certifications & Licensure

WA State Medical License 1989 - 2027
CT State Medical License 1995 - 1997
IL State Medical License 1986 - 1990
American Board of Internal Medicine Internal Medicine
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Start of enrollment: 1999 Dec 01
Completed
Phase 2
Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders Start of enrollment: 2000 Nov 01
Completed
Phase 1
Allogeneic Hematopoietic Stem Cell Transplantation for Induction of Mixed Hematopoietic Chimerism in Patients Infected With Human Immunodeficiency Virus-1 Using a Non-Marrow Ablative Conditioning Regimen Containing Total Body Irradiation in Combination Wi Start of enrollment: 2000 Nov 01
Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder Start of enrollment: 2002 Jan 01
Completed
Phase 1, Phase 2
Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) Start of enrollment: 2004 Jan 01
Completed
Phase 3
Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Start of enrollment: 2003 Apr 01
Completed
Phase 1, Phase 2
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer Start of enrollment: 1999 Nov 01
Completed
Not Applicable
Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease Start of enrollment: 2003 Aug 01
Completed
Phase 1, Phase 2
Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant Start of enrollment: 2006 Feb 01
Terminated
Phase 1
Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases Start of enrollment: 2006 Dec 01
Terminated
Phase 2
Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer Start of enrollment: 2007 Sep 01
Terminated
Phase 1, Phase 2
Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer Start of enrollment: 2009 Dec 17
Completed
Phase 2
Autologous Transplant in HIV Patients (BMT CTN 0803) Start of enrollment: 2010 Apr 01
Completed
Phase 2
Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas Start of enrollment: 2010 Oct 06
Completed
Phase 1, Phase 2
Selecting a Favorable KIR Donor in Unrelated HCT for AML Start of enrollment: 2011 Jun 01
Completed
Not Applicable
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RECRUITING
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation Start of enrollment: 2012 Feb 01
Recruiting
Phase 2
Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma Start of enrollment: 2015 Feb 01
Withdrawn
Not Applicable
Join now to see all

Publications & Presentations

PubMed

14 citations
Comparison of outcomes of HCT in blast phase of BCR-ABL1(-) MPN with de novo AML and with AML following MDS
Vikas Gupta, Soyoung Kim, Zhen-Huan Hu, Ying Liu, Mahmoud Aljurf
Blood Advances. 2020-10-13
16 citations
Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen mismatched donors
Brian Kornblit, Barry E. Storer, Niels Smedegaard Andersen, Michael B. Maris, Thomas R. Chauncey
Blood. 2020-09-24
22 citations
HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Nonmalignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide
Kanwaldeep K. Mallhi, Meera A. Srikanthan, Kelsey Baker, Haydar Frangoul, Troy R. Torgerson
Biology of Blood and Marrow Transplantation. 2020-07-01

Abstracts/Posters

Sirolimus Combined with Cyclosporine (CSP) and Mycophenolate Mofetil (MMF) As Graft-Vs-Host Disease (GVHD) Prophylaxis after Nonmyeloablative (NMA) Hematopoietic Cell ...
Ann Woolfrey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

From Bone Marrow to Mobilized Peripheral Blood Stem Cells: The Circuitous Path to Clinical Gene Therapy for Fanconi AnemiaClinically Relevant Abstract
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Strategies to Successfully Manage Complex Cell Therapy Clinical TrialsFebruary 10th, 2023
Cellular Immunotherapies for Leukemia PatientsJanuary 10th, 2017

Grant Support

Hematopoietic Cell Transplant: Platform For Purging The Latent HIV ReservoirNational Institute Of Allergy And Infectious Diseases2011
Developmental Regulation Of HLA DQ GenesNational Institute Of Diabetes And Digestive And Kidney Diseases1995–1999
Developmental Regulation Of HLA DQ GenesNational Institute Of Diabetes And Digestive And Kidney Diseases1995

Ann Elizabeth Woolfrey MD

Dr. Woolfrey is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Grant Support

Viewing the full profile is available to verified healthcare professionals only.